These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 28587486)

  • 41. Statistical optimization of controlled release microspheres containing cetirizine hydrochloride as a model for water soluble drugs.
    El-Say KM; El-Helw AR; Ahmed OA; Hosny KM; Ahmed TA; Kharshoum RM; Fahmy UA; Alsawahli M
    Pharm Dev Technol; 2015; 20(6):738-46. PubMed ID: 24856961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ocular tolerability of Eudragit RS100 and RL100 nanosuspensions as carriers for ophthalmic controlled drug delivery.
    Pignatello R; Bucolo C; Puglisi G
    J Pharm Sci; 2002 Dec; 91(12):2636-41. PubMed ID: 12434408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Indomethacin electrospun nanofibers for colonic drug delivery: In vitro dissolution studies.
    Akhgari A; Heshmati Z; Afrasiabi Garekani H; Sadeghi F; Sabbagh A; Sharif Makhmalzadeh B; Nokhodchi A
    Colloids Surf B Biointerfaces; 2017 Apr; 152():29-35. PubMed ID: 28064095
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl.
    Ali A; Iqbal M; Akhtar N; Khan HM; Ullah A; Uddin M; Khan MT
    Acta Pol Pharm; 2013; 70(2):283-9. PubMed ID: 23614284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parameters.
    Riekes MK; Dereymaker A; Berben P; Augustijns P; Stulzer HK; Van den Mooter G
    Int J Pharm; 2017 Mar; 520(1-2):49-58. PubMed ID: 28153650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and physicochemical evaluation of pharmacosomes of diclofenac.
    Semalty A; Semalty M; Singh D; Rawat MS
    Acta Pharm; 2009 Sep; 59(3):335-44. PubMed ID: 19819829
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Formulation and in vitro characterization of poly(dl-lactide-co-glycolide)/Eudragit RLPO or RS30D nanoparticles as an oral carrier of levofloxacin hemihydrate.
    Hasan AA; Sabry SA; Abdallah MH; El-Damasy DA
    Pharm Dev Technol; 2016 Sep; 21(6):655-63. PubMed ID: 25915180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design of new polymer carriers based of Eudragit E PO/Eudragit L100-55 interpolyelectrolyte complexes using swellability measurements.
    Moustafine RI; Bobyleva OV
    J Control Release; 2006 Nov; 116(2):e35-6. PubMed ID: 17718957
    [No Abstract]   [Full Text] [Related]  

  • 49. Formulation, preparation and dissolution characteristics of propranolol hydrochloride microspheres.
    Chiao CS; Price JC
    J Microencapsul; 1994; 11(2):153-9. PubMed ID: 8006762
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation and characterization of nebivolol nanoparticles using Eudragit® RS100.
    Jana U; Mohanty AK; Manna PK; Mohanta GP
    Colloids Surf B Biointerfaces; 2014 Jan; 113():269-75. PubMed ID: 24140793
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improvement of the antibacterial activity of daptomycin-loaded polymeric microparticles by Eudragit RL 100: an assessment by isothermal microcalorimetry.
    Ferreira IS; Bettencourt A; Bétrisey B; Gonçalves LM; Trampuz A; Almeida AJ
    Int J Pharm; 2015 May; 485(1-2):171-82. PubMed ID: 25772414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An in-vivo and in-vitro taste masking evaluation of bitter melt-extruded drugs.
    Maniruzzaman M; Bonnefille M; Aranyos A; Snowden MJ; Douroumis D
    J Pharm Pharmacol; 2014 Feb; 66(2):323-37. PubMed ID: 24180412
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparation and biopharmaceutical evaluation of nitrofurantoin loaded Eudragit RS100 and Eudragit RL 100 micropellets.
    Baidya S; Bedi S; Gupta BK
    Boll Chim Farm; 1999 May; 138(5):211-6. PubMed ID: 10450123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fabrication of modified transport fluconazole transdermal spray containing ethyl cellulose and Eudragit RS100 as film formers.
    Gohel MC; Nagori SA
    AAPS PharmSciTech; 2009; 10(2):684-91. PubMed ID: 19462250
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Formulation and process optimization of multiparticulate pulsatile system delivered by osmotic pressure-activated rupturable membrane.
    Hung SF; Hsieh CM; Chen YC; Lin CM; Ho HO; Sheu MT
    Int J Pharm; 2015 Mar; 480(1-2):15-26. PubMed ID: 25575473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and evaluation of buccoadhesive propranolol hydrochloride tablet formulations: effect of fillers.
    Akbari J; Nokhodchi A; Farid D; Adrangui M; Siahi-Shadbad MR; Saeedi M
    Farmaco; 2004 Feb; 59(2):155-61. PubMed ID: 14871508
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DEVELOPMENT AND EVALUATION OF IVABRADINE HCI-LOADED POLYMERIC MICROSPHERES PREPARED WITH EUDRAGIT L100-55 (METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER) AND ETHYL CELLULOSE FOR CONTROLLED DRUG RELEASE.
    Majeed A; Ranjha NM; Hanif M; Abbas G; Khan MA
    Acta Pol Pharm; 2017 Mar; 74(2):565-578. PubMed ID: 29624261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations.
    Nath B; Nath LK; Kumar P
    Acta Pol Pharm; 2011; 68(3):409-15. PubMed ID: 21648196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, statistical optimisation, characterisation and pharmacodynamic studies on Pioglitazone hydrochloride floating microparticles.
    Rao BP; Baby B; Mathews R; Rajarajan S; Haritha P; Ramesh K; Gupta NV
    J Microencapsul; 2014; 31(4):406-14. PubMed ID: 24697182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Swellable drug-polyelectrolyte matrices (SDPM). Characterization and delivery properties.
    Jimenez-Kairuz AF; Llabot JM; Allemandi DA; Manzo RH
    Int J Pharm; 2005 Jan; 288(1):87-99. PubMed ID: 15607261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.